脂蛋白和前血栓性影响:来自遗传关联研究的证据
Elena Olmastroni1, Julius L Katzmann2, Federica Galimberti3
1Epidemiology and Preventive Pharmacology Service (SEFAP), Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy; IRCCS MultiMedica, Sesto San Giovanni (MI), Italy.
European journal of internal medicine
|February 1, 2025
概括
升高的脂蛋白 (Lp) 与心肌梗塞 (MI) 风险有关,但与静脉血栓栓塞 (VTE) 风险无关. 这项研究没有发现证据表明Lp(a) 通过原血栓效应增加了心脏病发作风险.
科学领域:
- 心血管遗传学 心血管遗传学
- 血栓形成研究研究
- 脂质代谢 脂质代谢是什么
背景情况:
- 脂蛋白在心肌梗塞 (MI) 风险中的作用已经确立,但其前血栓性贡献仍然不清楚.
- 研究Lp(a) 的前血栓性作用对于了解其与心血管疾病的关联至关重要.
- 脂蛋白是动脉样硬化心血管疾病的独立风险因素.
研究的目的:
- 为了确定脂蛋白[Lp[a]是否具有促血栓性作用,有助于其与心肌梗塞 (MI) 风险相关联.
- 调查LPA遗传变异和Lp (a) 度与静脉血栓塞栓症 (VTE) 和心脏病风险的关联.
- 评估凝血途径是否会改变Lp(a) 和心脏病发作风险之间的关系.
主要方法:
- 利用了来自410,177名参与者的英国生物库数据.
- 检查了LPA遗传变异和Lp (a) 度与VTE和MI风险的关联.
- 通过对血栓 (F2/F5) 和血小板 (GUCY1A3) 途径的遗传分数进行分层分析.
主要成果:
- 无论是LPA遗传变异还是Lp (a) 度都与VTE风险无关.
- 观察到较高的Lp (a) 度和心脏病发作风险增加 (HR 1.31/100nmol/L) 之间存在强烈的关联.
- 影响凝血的遗传分数没有改变Lp(a) 和心脏病发作风险之间的关联.
结论:
- 脂蛋白 (Lp) 和心肌梗塞 (MI) 之间的联系并非由遗传决定的凝血活动介导.
- 这些发现不支持Lp(a) 相关的MI风险的原血栓机制.
- Lp (a) 可能通过非血栓性途径增加心脏病发作风险.
相关概念视频
Lipid-derived Compounds in the Human Body
Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...


